Molecular Diagnostics
Multi-Gene Panel Testing Catches Cancer Risk Variants
Over 608,000 patients with ovarian, breast, pancreatic, prostate and colorectal cancer are diagnosed each year. Current guidelines recommend testing all patients with ovarian and pancreatic cancer, as well as patients with prostate, breast and colorectal cancer (CRC) who meet certain criteria. More...25 Apr 2019
High-Res Genotyping Improves Survival for Stem Cell Transplantation
Allogeneic hematopoietic cell transplantation (HCT) provides a curative treatment option for individuals with hematologic diseases. Recipients and donors are considered to be compatible or “well matched” if they share a high degree of genetic similarity at their human leukocyte antigen (HLA) loci. More...25 Apr 2019
Sequencing Finds Germline Risk Variants in Pediatric Cancer Cases
Somatic panel sequencing is increasingly used in pediatric oncology to aid in cancer diagnosis, risk classification, identification of targetable biomarkers, and treatment planning. As tumor tissues contain both somatic and germline variants, tumor profiling can uncover potential germline changes incidentally. More...25 Apr 2019
Multiplex Assay Detects Pathogens in NF Patients
Necrotizing fasciitis (NF) is a life-threatening deep soft tissue infection characterized by rapidly progressive necrosis of the fascia and the adjacent soft tissues. NF of the extremities is associated with high mortality rates, and immediate surgical intervention is required upon detection of NF infections. More...23 Apr 2019
![Image: The MinION, a small hand-held device that \"decodes\" individual strands of DNA in real-time (Photo courtesy of Dr. Sophie Zaaijer).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2019-04-23/RLJ-157A.jpg "Image: The MinION, a small hand-held device that \\"decodes\\" individual strands of DNA in real-time (Photo courtesy of Dr. Sophie Zaaijer).")
DNA Sequencing Reduces Huntington's Disease Diagnosis
Huntington's disease is an inherited neuro-degenerative disorder, which stops parts of the brain working properly, with symptoms worsening over time, and is usually fatal within 20 years. Currently individuals with symptoms of Huntington's disease have a blood test and can wait up to four weeks for the result. More...23 Apr 2019
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Hybrid Pipette
SWITCH
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
In Other News
Suite of Risk Variants Revealed in Hirschsprung's Disease
Analysis of Melanoma Exosomes Identifies Potential Relapse Risk
CRC Gut Microbial Signatures Lead to Diagnostic Tests
Genomic Classifier Test for Lung Disease Validated
Rare Coding Mutations Associated with Alzheimer’s Disease
Genetic Diagnosis of Opitz C Syndrome Advanced
Genome-Wide Screening Identifies Pancreatic Cancer Biomarkers
Profiling of Blood Transcriptome Predicts Complications in Pregnancies
New Test May Replace ELISA for Detecting Antibodies
Fluorescent Markers May Aid Cancer Diagnostics by Tracking Metabolites
Nuclear Hormone Expression Predicts Cancer Aggressiveness
Fusion Genes Diagnosis Uses Targeted RNA Sequencing
Liquid Biopsy Potential Tested with ddPCR Technology
Malignant Pleural Mesothelioma Personalized by ctDNA Profiling
Fecal Microbes Used to Diagnose Liver Cirrhosis
Genomic Analysis Used to Diagnose Neurodevelopmental and Congenital Anomalies
Genomic Alterations and Expression Profiles Diagnose AEL
Digital PCR Assay Diagnoses Paucibacillary Leprosy
Immune Relationship to Lung Tumor Evolution Characterized
Glioblastoma Driver Mutations Appear Long Before Diagnosis
Preterm Birth Clues Identified in Cervicovaginal Microbiome
Biosensor Device Uses CRISPR-Cas9 to Detect Target DNA Sequence
Adverse Drug Response Risk Gene Identified for IBD
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.